Search results
Gateway - Quartz
Quartz· 11 hours agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly among poultry ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 6 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and olderHigher efficacy was observed in mRNA-1283 compared
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
The Kansas City Star· 6 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older
Gateway - Quartz
Quartz· 18 hours agoJohnson & Johnson agreed this week to settle a multi-state case alleging it misled consumers about the safety of its talc-based powder products. Moderna said its experimental ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
Morningstar· 4 days agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ ...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 6 days agoModerna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher efficacy in adults age 18 and older compared with its ...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 6 days ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoSince then, the stock has trended lower. The vaccine is based on protein technology, differentiating...
Gateway - Quartz
Quartz· 22 hours agoA new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both announced billion-dollar ...
A Trojan horse for government price-setting
Dallas Morning News· 2 days agoIn 2022, two small life-sciences firms — Genevant Sciences and Arbutus Biopharma — sued biotech giant Moderna for allegedly stealing their patented lipid...
